The Digene® HPV Test is the only such test approved by the FDA that uses advanced molecular technology to detect the DNA (genetic material) of 13 high-risk types of HPV (the virus shown to actually cause virtually all cases of cervical cancer.)
Approved by the FDA in 2003 for cervical cancer screening in conjunction with a Pap, in women age 30 and older – Digene® HPV Test – is based on proprietary “Hybrid Capture” technology, which combines two innovations from the rapidly evolving field of life sciences – DNA/RNA probes and monoclonal antibodies – to allow rapid, standardized gene testing …read more